Cholangiocarcinoma: The impact of tumor location and treatment strategy on outcome

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 4, 2003, Pages 422-428

  Heron, Dwight E ^a,c   Stein, David E ^b   Eschelman, David J ^b   Topham, Allan K ^b   Waterman, Frank M ^b   Rosato, Ernest L ^b   Alden, Mark ^b   Anne, Pramila Rani ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cholangiocarcinoma; Extrahepatic; Radiation therapy; Surgery

Indexed keywords

DOXORUBICIN; FLUOROURACIL; IRIDIUM 192; MITOMYCIN C; PACLITAXEL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CATHETER; CATHETERIZATION; CHOLEDOCHOJEJUNOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HEPATOJEJUNOSTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PROGNOSIS; RADIATION BEAM; ROUX Y ANASTOMOSIS; STENT; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION; UNIVERSITY HOSPITAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILIARY TRACT SURGICAL PROCEDURES; BRACHYTHERAPY; CHOLANGIOCARCINOMA; HUMANS; PALLIATIVE CARE; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0042563320     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200308000-00024     Document Type: Article

References (33)

1. Blumgart L, Thompson J. The management of malignant strictures of the bile duct. Curr Prob Surg 1987;24:69-127.
2. Voravud N, Foster CS, Gilbertson JA, et al. Oncogene expression in cholangiocarcinoma and in normal hepatic development. Hum Pathol 1989;20:1163-8.
3. Karani J, Fletcher M, Brinkley D, et al. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 1985;36:603-6.
4. Meyer WC, Jones RS. Internal radiation for bile duct cancer. World J Surg 1988;12:99-104.
5. Blumgart L, Hadjis NS. Proximal bile duct cancer: curative resection or palliative bypass. In: Wanebo HJ. Hepatic and biliary cancer. New York: Marcel Dekker, 1987:375-94.
6. Schoenthaler R, Phillips TL, Wetter A, et al. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience [Abstract]. Int J Radiat Oncol Biol Phys 1992; 24(suppl 1):213.
7. Schoenthaler R, Castro JR, Halberg FE, et al. Definitive postoperative irradiation of bile duct carcinoma with charge particle and/or photons. Int J Radiat Oncol Biol Phys 1993;27:75-82.
8. Schoenthaler R, Phillips TL, Castro J, et al. Carcinoma of the extrahepatic bile duct: the University of California at San Francisco experience. Ann Surg 1994;219:267-74.
9. Reding R, Buard JL, Lebeau G, et al. Surgical management of 552 carcinomas of the extrahepatic bile duct (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 1991;213:236-41.
10. Langer JC, Langer B, Taylor BR, et al. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery 1985;98:752-9.
11. Boerma E. Research in the results of resection of the hilar bile duct cancer. Surgery 1990;108:572-80.
12. Kopelson G, Galdabibi J, Warshaw AL, et al. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: implications for adjuvant therapy. Int J Radiat Biol Phys 1981;7: 413-7.
13. Alden ME, Waterman FM, Topham AK, et al. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct. Radiology 1995;197:511-6.
14. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994;28:945-51.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;54:457-81.
16. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Boimetrika 1965;52:203-22.
17. Wolkov HB, Graves GM, Won M, et al. Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506. Am J Clin Oncol 1992;15:323-7.
18. Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995;221:788-97.
19. Urego M, Flickinger JC, Carr BI. Radiotherapy and the multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1999;44:121-6.
20. Buskirk SJ, Gunderson LL, Schild SE, et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 1992;215:125-31.
21. Minsky BD, Wesson MF, Armstrong JG, et al. Combined modality therapy for extrahepatic biliary system cancer. Int J Radiat Oncol Biol Phys 1990;18:1157-63.
22. Veeze-Kuijpers B, Meerwaldt JH, Lameris JS, et al. The role of radiotherapy in the treatment of bile duct carcinoma. Int J Radiat Oncol Biol Phys 1990;18:63-6.
23. Vebreek PC, Van Leeuwen DJ, Van Der Heyd MN, et al. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis of sixty-four patients. Ann Chir 1991;45:350-4.
24. Fields JN, Emami B. Carcinoma of the extrahepatic biliary system - results of primary and adjuvant brachytherapy. Int J Radiat Oncol Biol Phys 1987;13:331-8.
25. Zlotecki RA, Jung LA, Vauthey JN, et al. Carcinoma of the extrahepatic biliary tract: surgery and radiotherapy for curative and palliative intent. Radiat Oncol Investig 1998;6:240-7.
26. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996;224:463-73.
27. Lotze M, Flickinger J, Carr B. Hepatobiliary neoplasms. In: Devita V Jr, Hellman SA, Rosenberg S. Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1993:883.
28. Falkson G, MacIntyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984;54:965-9.
29. Flickinger JC, Epstein AH, Iwatsuki S, et al. Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer 1991;68:289-94.
30. Fritz P, Brambs HJ, Schraube P, et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys 1994;29:855- 61.
31. Kamada T, Saitou H, Takamura A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 1996;34:767-74.
32. Nordback IH, Pitt HA, Coleman J, et al. Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery 1994;115:597-603.
33. Eschelman DJ, Shapiro MJ, Bonn J, et al. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology 1996;2000:717-24.